How should a transdermal fentanyl patch be converted to an intravenous fentanyl infusion in an opioid‑tolerant patient?

Converting Transdermal Fentanyl Patch to Intravenous Fentanyl

Use a 1:1 conversion ratio when converting from transdermal fentanyl patch to intravenous fentanyl infusion in opioid-tolerant patients. This means the mcg/hour rate of the transdermal patch directly equals the mcg/hour rate of the IV infusion 1.

Conversion Algorithm

Step 1: Identify the Current Transdermal Dose

• Determine the total mcg/hour delivery rate from all fentanyl patches currently applied
• If multiple patches are used, add them together (e.g., two 50 mcg/hr patches = 100 mcg/hr total)

Step 2: Remove Patches and Initiate IV Infusion Simultaneously

• Remove all transdermal fentanyl patches
• Immediately start continuous IV fentanyl infusion at the same hourly rate (e.g., 50 mcg/hr patch → 50 mcg/hr IV infusion) 2
• This simultaneous approach prevents gaps in analgesia while accounting for the depot effect of residual fentanyl in subcutaneous tissue

Step 3: Provide Breakthrough Medication

• Make IV fentanyl boluses available via patient-controlled analgesia (PCA)
• Set demand boluses at 50-100% of the continuous infusion rate 2
• Example: For 50 mcg/hr infusion, allow 25-50 mcg boluses as needed

Step 4: Monitor and Titrate

• Assess pain intensity at rest and with movement at least daily
• Monitor for sedation and respiratory depression, especially in the first 24 hours
• Titrate the continuous infusion rate based on pain control and supplemental PCA use 2
• Most patients achieve adequate pain control (pain score ≤4 at rest) within 1.5-5 days 2

Critical Clinical Considerations

Pharmacokinetic Rationale: The 1:1 conversion is appropriate because both routes deliver fentanyl systemically, bypassing first-pass metabolism. The transdermal route has already established steady-state levels, and the IV route maintains similar bioavailability 1.

Timing Considerations: After patch removal, serum fentanyl concentrations decline gradually with a mean half-life of approximately 17 hours due to continued absorption from the subcutaneous depot 3. The immediate initiation of IV fentanyl at the same rate compensates for this gradual decline while preventing overdose.

Safety Profile: Research demonstrates this 1:1 conversion can be accomplished safely without serious adverse effects when properly monitored 2. All nine patients in the key study achieved improved pain control without significant complications.

Common Pitfalls to Avoid

• Do not delay IV initiation: Waiting for patch effects to wear off creates unnecessary pain gaps
• Do not reduce the initial IV dose: The 1:1 ratio already accounts for route differences; further reduction leads to inadequate analgesia
• Do not use conversion tables designed for other opioids: Tables for converting oral morphine or other opioids to transdermal fentanyl are conservative and should never be reversed for this conversion 3, 4
• Do not forget the depot effect: Residual fentanyl continues absorbing from skin for 12-24 hours after patch removal, requiring vigilant monitoring 3

Special Populations

Acute pain exacerbations: This conversion is particularly effective for hospitalized cancer patients experiencing severe pain episodes where rapid titration is needed 2. The IV route allows immediate dose adjustments that are impossible with the 72-hour patch duration.

Renal dysfunction: Fentanyl is preferred over morphine or hydromorphone in patients with renal impairment, as it lacks renally-cleared toxic metabolites 5, 6. The 1:1 conversion remains appropriate in this population.